08172017Headline:

Dallas, Texas

HomeTexasDallas

Email RLF Staff RLF Staff on LinkedIn RLF Staff on Twitter RLF Staff on Facebook
RLF Staff
RLF Staff
Contributor •

FDA RECALL – V.MAX Erectile Dysfunction (ED) supplement

Comments Off

From MedWatch – The FDA Safety Information and Adverse Event Reporting Program

Barodon SF and FDA notified consumers and healthcare professionals of a voluntary nationwide recall of a supplement product sold under the name V.MAX. Lab analysis by FDA of product samples found the product contains Aminotadalafil, an analogue of Tadalafil, an FDA-approved drug used to treat Erectile Dysfunction (ED). FDA advised that this poses a threat to consumers because Aminotadalafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
Consumers who have V.MAX in their possession should stop using it immediately and contact their physician if they experienced any problem that may be related to taking this product.

Read the complete MedWatch 2007 Safety summary, including a link to the firm press release, at:

http://www.fda.gov/medwatch/safety/2007/safety07.htm#vmax